Vol. 17 No. 1 (2013)
CORONARY ARTERY DISEASES

Comparative estimation of indirect revascularisation efficacy in IHD surgery

A. Chernyavskiy
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
A. Fomichev
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
M. Chernyavskiy
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
P. Larionov
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
V. Bondar
Federal Center of Cardiovascular Surgery, Khabarovsk
Bio
D. Sergeevichev
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio

Published 2013-04-05

Keywords

  • ISCHEMIC HEART DISEASE,
  • TRANSMYOCARDIAL LASER REVASCULARIZATION,
  • MONONUCLEAR FRACTION OF RED BONE MARROW

How to Cite

Chernyavskiy, A., Fomichev, A., Chernyavskiy, M., Larionov, P., Bondar, V., & Sergeevichev, D. (2013). Comparative estimation of indirect revascularisation efficacy in IHD surgery. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 17(1), 15–20. https://doi.org/10.21688/1681-3472-2013-1-15-20

Abstract

The aim of the study was to compare the efficacy of different techniques of indirect myocardial revascularization: transmyocardial laser revascularization and concomitant injection of mononuclear fraction of red bone marrow in laser canals during surgical treatment of ischemic heart disease. The efficacy was evaluated on the basis of echocardiography and perfusion scintigraphy data obtained in two weeks, 6 months, 12 months and 3 years after operation. Implantation of a mononuclear fraction of red bone marrow into laser canals proved to be the most effective technique. It was confirmed by a significant decrease in angina functional class and a more pronounced increase in myocardial perfusion and contractility.

References

  1. Бокерия Л.А. Минимально инвазивная хирургия сердца. М., 1998.
  2. Boyle A.J., Schulman S.P., Hare J.M. // Circulation. 2006. V. 214. P. 339-352.
  3. Babin-Ebell J., Sievers H.H., Charitos E.I. et al. // Thorac. Cardiovasc. Surg. 2010. V. 58 (1). P. 11-16.
  4. Beeres S.L., Bax J.J., Dibbets P. // J. Nucl. Med. 2006. V. 47 (4). P. 574-580.
  5. Cooley D.A., Moore W.H., Wilansky S. et al. // J. Thorac. Cardiovasc. Surg. 1996. V. 111. P. 791-797.
  6. Dallan L.A., Gowdak L.H., Lisboa L.A. // Rev. Bras. Cir. Cardiovasc. 2008. V. 23 (1). P. 46-52.
  7. Donndorf P., Kundt G., Kaminski A. // Thorac. Cardiovasc. Surg. 2011.
  8. Frazier O.H., Kadipasaoglu K. // Curr. Opin. Cardiol. 1996. V. 11. Р. 564-567.
  9. Horvath K. // Ann. Thorac. Surg. 1998. V. 65. P. 1439-1441.
  10. McGillion M., Cook A., Victor J.C. // Vasc. Health Risk. Manag. 2010. V. 7. P. 735-747.
  11. Moosdorf R., Maisch B. et al. // Herz. 1997. V. 22. Р. 198-204.
  12. Oguz E., Ayik F., Ozturk P. et al. // Transplant. Proc. 2011. V. 43 (3). P. 931-934.
  13. Reyes G., Allen K.B., Aguado B., Duarte J. // Eur. J. Cardiothorac. Surg. 2009. V. 36 (1). P. 192-194.
  14. Rivas-Plata A., Castillo J., Pariona M., Chunga A. // Asian Cardiovasc. Thorac. Ann. 2010. V. 18 (5). P. 425.
  15. Wen Y., Meng L., Xie J., Ouyang J. // Expert Opin. Biol. Ther. 2011. V. 11 (5). P. 559-567.
  16. Yamamoto N., Kohmoto T., Gu A. et al. // J. Am. Coll. Cardiol. 1998. V. 31. Р. 1426-1433.